Related Experiment Videos

The effect of age upon the affinity of microsomal mono-oxygenase enzymes for substrate in human liver

H A Wynne1, E Mutch, O F James

  • 1Department of Medicine (Geriatrics), University of Newcastle upon Tyne.

Age and Ageing
|November 1, 1988
PubMed

Insights

Drug clearance decreases with age, but enzyme activity in human liver does not. This study found no age-related changes in enzyme affinity, suggesting other factors like reduced liver size or blood flow impact drug metabolism.

Area of Science:

  • Pharmacology
  • Gerontology
  • Biochemistry

Background:

  • Drug clearance often declines in older adults.
  • Maximal drug-metabolizing enzyme activities typically remain unchanged with age.
  • The impact of aging on enzyme-substrate affinity in human liver is not well understood.

Purpose of the Study:

  • To investigate whether enzyme affinity for substrates decreases with age in human liver.
  • To examine the kinetics of microsomal mono-oxygenase 7-ethoxycoumarin-O-de-ethylase in relation to age.

Main Methods:

  • Studied the kinetics of 7-ethoxycoumarin-O-de-ethylase in 17 human liver biopsy specimens.
  • Analyzed correlations between age and enzyme activity, affinity, and protein recovery.

Main Results:

  • No significant correlation was found between age and microsomal protein recovery.
  • Maximal enzyme activity showed no age-dependent decline.
  • Apparent enzyme affinity for the substrate did not correlate with age.

Conclusions:

  • Enzyme activity and affinity of microsomal mono-oxygenase do not appear to change with age in the human liver.
  • The decline in drug clearance with aging is likely due to factors other than altered enzyme kinetics, such as reduced liver volume or blood flow.

Related Concept Videos